Interval exercise training in cystic fibrosis - Effects on exercise capacity in severely affected adults

被引:37
|
作者
Gruber, Wolfgang [1 ]
Orenstein, David M. [2 ]
Braumann, Klaus M. [1 ]
Beneke, Ralph [3 ]
机构
[1] Univ Hamburg, Inst Sports & Exercise Med, D-20148 Hamburg, Germany
[2] Univ Pittsburgh, Sch Educ, Sch Med, Pittsburgh, PA 15201 USA
[3] Univ Marburg, Dept Med Training & Hlth, D-35032 Marburg, Germany
关键词
Exercise capacity; Interval training; Responsiveness; Severely affected subjects; CHRONIC HEART-FAILURE; REHABILITATION; CHILDREN; FITNESS; RESPONSES; QUALITY; PROGRAM; MUSCLE;
D O I
10.1016/j.jcf.2013.06.005
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The aims of the present study were to investigate the effects of IT on lung function power (P) and oxygen uptake (VO2) at peak performance (peak) and ventilatory anaerobic threshold (VAT) in CF patients who were unable to participate in a standard exercise program (SEP) and to compare these IT responses with corresponding effects in CF patients performing SEP. 20 patients (FEV1 25.5 +/- 7.5%; pred; SpO2 < 90% at rest or P lower than 0.3 W/kg) who were unable to participate in SEP were allocated to IT (5 x 20 min weekly). 23 patients (FEV1 31.6 +/- 4.2%; p < 0.05) did 5 x 45 min per week of SEP. Lung function remained unchanged in both groups. VO2peak and PVAT increased in both groups (p < 0.05). However, only after the SEP an increase in Ppeak (p < 0.05) and only after IT a higher VO2VAT (p < 0.05) were found. Compared to SEP, IT improved submaximal exercise capacity to a greater extent whereas responsiveness on peak performance was higher in SEP. This seems to indicate a specific potential of IT for positive peripheral muscular adaptations in spite of diminishing potential of pulmonary improvement. IT represents an alternative, effective and safe training regimen with patients with CF and severe lung disease, with a greater potential than SEP. (C) 2013 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:86 / 91
页数:6
相关论文
共 50 条
  • [41] The evolution of exercise capacity and its limiting factors in Cystic Fibrosis
    Almajed, Athari
    Lands, Larry C.
    PAEDIATRIC RESPIRATORY REVIEWS, 2012, 13 (04) : 195 - 199
  • [42] MULTIPLE FACTORS LIMIT EXERCISE CAPACITY IN CYSTIC-FIBROSIS
    MARCOTTE, JE
    GRISDALE, RK
    LEVISON, H
    COATES, AL
    CANNY, GJ
    PEDIATRIC PULMONOLOGY, 1986, 2 (05) : 274 - 281
  • [43] THE RELATIONSHIP BETWEEN EXERCISE CAPACITY AND HOSPITALISATION IN ADULT CYSTIC FIBROSIS
    Barry, R.
    Chambers, R.
    Smith, D.
    Walsh, J.
    Roll, M.
    Hall, K.
    Cobb, R.
    Morris, N.
    RESPIROLOGY, 2017, 22 : 57 - 57
  • [44] Oxygen Uptake Kinetics and Exercise Capacity in Children With Cystic Fibrosis
    Fielding, Jeremy
    Brantley, Lucy
    Seigler, Nichole
    McKie, Katie T.
    Davison, Gareth W.
    Harris, Ryan A.
    PEDIATRIC PULMONOLOGY, 2015, 50 (07) : 647 - 654
  • [45] Exercise Capacity and Lung Function in Cystic Fibrosis: A Longitudinal Approach
    Daniel, Tessa R.
    Seigler, Nichole
    Harris, Ryan A.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2014, 46 (05): : 151 - 151
  • [46] AEROBIC EXERCISE CAPACITY IN PRE TEENAGE CYSTIC FIBROSIS CHILDREN
    Widger, J.
    Kilbride, E.
    Elnazir, B.
    Greally, P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2010, 179 : S190 - S190
  • [47] Peripheral muscle weakness and exercise capacity in children with cystic fibrosis
    de Meer, K
    Gulmans, VAM
    van der Laag, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : 748 - 754
  • [48] Relationship between exercise capacity and glucose tolerance in cystic fibrosis
    Foster, Karla
    Huang, Guixia
    Zhang, Nanhua
    Crisalli, Joseph
    Chini, Barbara
    Amin, Raouf
    Elder, Deborah
    PEDIATRIC PULMONOLOGY, 2018, 53 (02) : 154 - 161
  • [49] Exercise capacity in patients with cystic fibrosis vs. non-cystic fibrosis bronchiectasis
    Bar-Yoseph, Ronen
    Ilivitzki, Anat
    Cooper, Dan M.
    Gur, Michal
    Mainzer, Gur
    Hakim, Fahed
    Livnat, Galit
    Schnapp, Zeev
    Shalloufeh, George
    Zucker-Toledano, Merav
    Subar, Yael
    Bentur, Lea
    PLOS ONE, 2019, 14 (06):
  • [50] EFFECT OF LUMACAFTOR/IVACAFTOR ON EXERCISE CAPACITY IN PATIENTS WITH CYSTIC FIBROSIS
    Tucker, M. A.
    Seigler, N.
    Rodriguez, Miguelez P.
    McKie, K. T.
    Forseen, C.
    Crandall, R. H.
    Harris, R. A.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S393 - S393